{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:07:20Z","timestamp":1773860840262,"version":"3.50.1"},"reference-count":93,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/phm.0b013e31804a83cf","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T08:04:09Z","timestamp":1176883449000},"page":"412-421","source":"Crossref","is-referenced-by-count":10,"title":["Motor Neuron Inhibition\u2013Based Gene Therapy for Spasticity"],"prefix":"10.1097","volume":"86","author":[{"given":"Shearwood","family":"McClelland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingshan","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndsey S.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas M.","family":"Boulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210202","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1083\/jcb.82.3.798","article-title":"Selective retrograde transsynaptic transfer of a protein, tetanus toxin, subsequent to its retrograde axonal transport.","volume":"82","author":"Schwab","year":"1979","journal-title":"J Cell Biol"},{"key":"R2-13-20210202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1113\/jphysiol.1898.sp000697","article-title":"Decerebrate rigidity and reflex coordination of movements.","volume":"22","author":"Sherrington","year":"1898","journal-title":"J Physiol (Lond)"},{"key":"R3-13-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<153::AID-MUS3>3.0.CO;2-4","article-title":"The surgical treatment of spasticity.","volume":"23","author":"Smyth","year":"2000","journal-title":"Muscle Nerve"},{"key":"R4-13-20210202","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.20285","article-title":"Pathophysiology of spastic paresis. II: Emergence of muscle overactivity.","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"},{"key":"R5-13-20210202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/mus.20284","article-title":"Pathophysiology of spastic paresis. I: Paresis and soft tissue changes.","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"},{"key":"R6-13-20210202","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1047-9651(18)30030-5","article-title":"Physiologic and clinical monitoring of spastic hypertonia.","volume":"12","author":"Hinderer","year":"2001","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"suppl 1","key":"R7-13-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1468-1331.2002.0090s1003.x","article-title":"The pathophysiology of spasticity.","volume":"9","author":"Sheean","year":"2002","journal-title":"Eur J Neurol"},{"key":"R8-13-20210202","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/0140-6736(90)90389-M","article-title":"What is spasticity?","volume":"335","author":"Lance","year":"1990","journal-title":"Lancet"},{"issue":"10 suppl","key":"R9-13-20210202","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.PHM.0000141125.28611.3E","article-title":"Spasticity: the misunderstood part of the upper motor neuron syndrome.","volume":"83","author":"Ivanhoe","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"R10-13-20210202","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archneur.1987.00520220039013","article-title":"The GABA-agonist progabide for spasticity in multiple sclerosis.","volume":"44","author":"Rudick","year":"1987","journal-title":"Arch Neurol"},{"key":"R11-13-20210202","first-page":"1","article-title":"Management of spasticity and painful spasms in Paraplegia.","volume":"9","author":"Scott","year":"1987","journal-title":"Contemp Neurosurg"},{"key":"R12-13-20210202","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/(SICI)1097-4598(1997)6+<92::AID-MUS7>3.0.CO;2-E","article-title":"Traditional pharmacological treatments for spasticity. Part II: general and regional treatments.","volume":"6","author":"Gracies","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"R13-13-20210202","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003495-199753030-00007","article-title":"Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.","volume":"53","author":"Wagstaff","year":"1997","journal-title":"Drugs"},{"key":"R14-13-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1742-1241.1989.tb08783.x","article-title":"Botulinum toxin in treating spasticity.","volume":"43","author":"Das","year":"1989","journal-title":"Br J Clin Pract"},{"key":"R15-13-20210202","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.micro.53.1.551","article-title":"Clostridial toxins as therapeutic agents: benefits of nature\u2019s most toxic proteins.","volume":"53","author":"Johnson","year":"1999","journal-title":"Annu Rev Microbiol"},{"key":"R16-13-20210202","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","article-title":"Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.","volume":"46","author":"Simpson","year":"1996","journal-title":"Neurology"},{"key":"R17-13-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/154596830101500108","article-title":"The estimated cost of managing focal spasticity: a physician practice patterns survey.","volume":"15","author":"Radensky","year":"2001","journal-title":"Neurorehabil Neural Repair"},{"key":"R18-13-20210202","first-page":"354","article-title":"Handbook of Neurosurgery ed 5.","author":"Greenberg","year":"2001"},{"key":"R19-13-20210202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/00016470510030454","article-title":"Adductor tenotomy in spastic cerebral palsy. A long-term follow-up study of 78 patients.","volume":"76","author":"Terjesen","year":"2005","journal-title":"Acta Orthop"},{"key":"R20-13-20210202","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/jns.1993.78.2.0226","article-title":"Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.","volume":"78","author":"Coffey","year":"1993","journal-title":"J Neurosurg"},{"issue":"1 suppl","key":"R21-13-20210202","first-page":"9","article-title":"Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients.","volume":"104","author":"Vender","year":"2006","journal-title":"J Neurosurg"},{"key":"R22-13-20210202","first-page":"177","article-title":"Pharmacological complications of the chronic baclofen infusion in the severe spinal spasticity. Personal experience and review of the literature.","volume":"48","author":"Dario","year":"2004","journal-title":"J Neurosurg Sci"},{"key":"R23-13-20210202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0303-8467(02)00009-4","article-title":"Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen.","volume":"104","author":"Nielsen","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"R24-13-20210202","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.sc.3101471","article-title":"Treatment of spasticity in a spinal cord-injured patient with intrathecal morphine due to intrathecal baclofen tolerance\u2014a case report and review of literature.","volume":"41","author":"Soni","year":"2003","journal-title":"Spinal Cord"},{"key":"R25-13-20210202","first-page":"516","article-title":"Intrathecal baclofen: does tolerance occur?","volume":"31","author":"Akman","year":"1993","journal-title":"Paraplegia"},{"key":"R26-13-20210202","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1053\/jpsu.2002.32928","article-title":"Recurrent intrathecal baclofen pump catheter leakage: A surgical observation with recommendations.","volume":"37","author":"Dickerman","year":"2002","journal-title":"J Pediatr Surg"},{"key":"R27-13-20210202","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3171\/jns.1985.62.4.0558","article-title":"Immediate effects of spinal cord stimulation in spinal spasticity.","volume":"62","author":"Barolat-Romana","year":"1985","journal-title":"J Neurosurg"},{"key":"R28-13-20210202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.sc.3101263","article-title":"Spinal cord stimulation facilitates functional walking in a chronic, incomplete spinal cord injured.","volume":"40","author":"Herman","year":"2002","journal-title":"Spinal Cord"},{"key":"R29-13-20210202","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/cns.1986.3.129","article-title":"Spinal cord stimulation for the control of spasticity in patients with chronic spinal cord injury: I. Clinical observations.","volume":"3","author":"Dimitrijevic","year":"1986","journal-title":"Cent Nerv Syst Trauma"},{"key":"R30-13-20210202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/cns.1986.3.145","article-title":"Spinal cord stimulation for the control of spasticity in patients with chronic spinal cord injury: II. Neurophysiologic observations.","volume":"3","author":"Dimitrijevic","year":"1986","journal-title":"Cent Nerv Syst Trauma"},{"key":"R31-13-20210202","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1227\/00006123-198804000-00015","article-title":"Cervical spinal cord stimulation for spasticity in cerebral palsy.","volume":"22","author":"Hugenholtz","year":"1988","journal-title":"Neurosurgery"},{"key":"R32-13-20210202","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.sc.3100532","article-title":"Epidural spinal cord stimulation for the control of spasticity in spinal cord injury patients lacks long-term efficacy and is not cost-effective.","volume":"36","author":"Midha","year":"1998","journal-title":"Spinal Cord"},{"key":"R33-13-20210202","first-page":"29","article-title":"Effects of spinal cord stimulation on spasticity and spasms secondary to myelopathy.","volume":"51","author":"Barolat","year":"1988","journal-title":"Appl Neurophysiol"},{"key":"R34-13-20210202","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01405946","article-title":"Sectorial posterior rhizotomy, a new technique of surgical treatment for spasticity.","volume":"35","author":"Privat","year":"1976","journal-title":"Acta Neurochir (Wien)"},{"key":"R35-13-20210202","first-page":"335","article-title":"Results of selective posterior rhizotomy in the treatment of painful and spastic paraplegia secondary to multiple sclerosis.","volume":"45","author":"Sindou","year":"1982","journal-title":"Appl Neurophysiol"},{"key":"R36-13-20210202","article-title":"Orthopaedic Management in Cerebral Palsy.","author":"Bleck","year":"1987"},{"key":"R37-13-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3171\/jns.1997.86.1.0034","article-title":"Selective dorsal rhizotomy and rates of orthopedic surgery in children with spastic cerebral palsy.","volume":"86","author":"Chicoine","year":"1997","journal-title":"J Neurosurg"},{"key":"R38-13-20210202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1302\/0301-620X.85B2.14066","article-title":"Musculoskeletal aspects of cerebral palsy.","volume":"85","author":"Graham","year":"2003","journal-title":"J Bone Joint Surg Br"},{"key":"R39-13-20210202","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01202412-200507000-00007","article-title":"Prevention of severe contractures might replace multilevel surgery in cerebral palsy: results of a population-based health care programme and new techniques to reduce spasticity.","volume":"14","author":"Hagglund","year":"2005","journal-title":"P Pediatr Orthop B"},{"key":"R40-13-20210202","first-page":"345","article-title":"Pediatric Orthopaedics.","author":"Rang","year":"1986"},{"key":"R41-13-20210202","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01241398-199107000-00014","article-title":"Rapid progression of hip subluxation in cerebral palsy after selective posterior rhizotomy.","volume":"11","author":"Greene","year":"1991","journal-title":"J Pediatr Orthop"},{"issue":"24 suppl","key":"R42-13-20210202","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1097\/00007632-200112151-00024","article-title":"Pain and spasticity after spinal cord injury: mechanisms and treatment.","volume":"26","author":"Burchiel","year":"2001","journal-title":"Spine"},{"key":"R43-13-20210202","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1227\/00006123-199002000-00018","article-title":"The management of paralytic spasticity.","volume":"26","author":"Herz","year":"1990","journal-title":"Neurosurgery"},{"key":"R44-13-20210202","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1227\/00006123-198410000-00009","article-title":"A prospective study of radiofrequency rhizotomy in the treatment of posttraumatic spasticity.","volume":"15","author":"Kasdon","year":"1984","journal-title":"Neurosurgery"},{"key":"R45-13-20210202","first-page":"306","article-title":"Percutaneous sacral thermorhizotomy to treat equinism of spastic cerebral palsy children [in French].","volume":"49","author":"Frerebeau","year":"2003","journal-title":"Neurochirurgie"},{"key":"R46-13-20210202","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1002\/(SICI)1097-4598(1997)6+<221::AID-MUS16>3.0.CO;2-8","article-title":"Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity.","volume":"6","author":"Albany","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"R47-13-20210202","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1073\/pnas.92.13.5955","article-title":"Elimination of potassium channel expression by antisense oligonucleotides in a pituitary cell line.","volume":"92","author":"Chung","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R48-13-20210202","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1113\/jphysiol.1997.sp021998","article-title":"Shal-type channels contribute to the Ca2+-independent transient outward K+ current in rat ventricle.","volume":"500","author":"Fiset","year":"1997","journal-title":"J Physiol"},{"key":"R49-13-20210202","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/329219a0","article-title":"Functional inactivation of genes by dominant negative mutations.","volume":"329","author":"Herskowitz","year":"1987","journal-title":"Nature"},{"key":"R50-13-20210202","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1172\/JCI118103","article-title":"Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitability.","volume":"96","author":"Johns","year":"1995","journal-title":"J Clin Invest"},{"key":"R51-13-20210202","doi-asserted-by":"crossref","first-page":"31598","DOI":"10.1074\/jbc.272.50.31598","article-title":"Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs.","volume":"272","author":"Johns","year":"1997","journal-title":"J Biol Chem"},{"key":"R52-13-20210202","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nm1195-1116","article-title":"The state of the art in antisense research.","volume":"1","author":"Wagner","year":"1995","journal-title":"Nat Med"},{"key":"R53-13-20210202","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/sj.gt.3302223","article-title":"Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior.","volume":"11","author":"Noordmans","year":"2004","journal-title":"Gene Ther"},{"key":"R54-13-20210202","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1098-1136(199801)22:1<86::AID-GLIA8>3.0.CO;2-6","article-title":"Glutamate-modulated production of GABA in immortalized astrocytes transduced by a glutamic acid decarboxylase-expressing retrovirus.","volume":"22","author":"Sacchettoni","year":"1998","journal-title":"Glia"},{"key":"R55-13-20210202","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/sj.gt.3300521","article-title":"Adenovirus-mediated transfer of a functional GAD gene into nerve cells: potential for the treatment of neurological diseases.","volume":"4","author":"Robert","year":"1997","journal-title":"Gene Ther"},{"key":"R56-13-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-4547(19990701)57:1<137::AID-JNR15>3.0.CO;2-D","article-title":"Recombinant adeno-associated virus (AAV) drives constitutive production of glutamate decarboxylase in neural cell lines.","volume":"57","author":"Mi","year":"1999","journal-title":"J Neurosci Res"},{"key":"R57-13-20210202","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1074549","article-title":"Subthalamic GAD gene therapy in a Parkinson\u2019s disease rat model.","volume":"298","author":"Luo","year":"2002","journal-title":"Science"},{"key":"R58-13-20210202","first-page":"1589","article-title":"Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.","volume":"12","author":"During","year":"2001","journal-title":"Hum Gene Ther"},{"key":"R59-13-20210202","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.gt.3302400","article-title":"Adenoviral clostridial light chain gene-based synaptic inhibition through neuronal synaptobrevin elimination.","volume":"12","author":"Teng","year":"2005","journal-title":"Gene Ther"},{"key":"R60-13-20210202","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1523\/JNEUROSCI.23-17-06759.2003","article-title":"Reversible suppression of glutamatergic neurotransmission of cerebellar granule cells in vivo by genetically manipulated expression of tetanus neurotoxin light chain.","volume":"23","author":"Yamamoto","year":"2003","journal-title":"J Neurosci"},{"key":"R61-13-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release.","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"key":"R62-13-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0041-0101(00)00163-X","article-title":"Tetanus and botulinum neurotoxins: turning bad guys into good by research.","volume":"39","author":"Rossetto","year":"2001","journal-title":"Toxicon"},{"key":"R63-13-20210202","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","article-title":"Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.","volume":"359","author":"Schiavo","year":"1992","journal-title":"Nature"},{"key":"R64-13-20210202","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1523\/JNEUROSCI.19-05-01691.1999","article-title":"Inducible genetic suppression of neuronal excitability.","volume":"19","author":"Johns","year":"1999","journal-title":"J Neurosci"},{"key":"R65-13-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0076-6879(00)27292-3","article-title":"Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances.","volume":"327","author":"Baron","year":"2000","journal-title":"Methods Enzymol"},{"key":"R66-13-20210202","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1073\/pnas.91.17.8180","article-title":"A regulatory system for use in gene transfer.","volume":"91","author":"Wang","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R67-13-20210202","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.283.5398.88","article-title":"Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.","volume":"283","author":"Ye","year":"1999","journal-title":"Science"},{"key":"R68-13-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/mthe.1999.0023","article-title":"Adenovirus-mediated inducible gene expression in vivo by a hybrid ecdysone receptor.","volume":"1","author":"Hoppe","year":"2000","journal-title":"Mol Ther"},{"key":"R69-13-20210202","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2005.01.022","article-title":"A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting.","volume":"19","author":"Liu","year":"2005","journal-title":"Neurobiol Dis"},{"key":"R70-13-20210202","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ydbio.2005.04.017","article-title":"Identification of a conserved 125 base-pair Hb9 enhancer that specifies gene expression to spinal motor neurons.","volume":"283","author":"Nakano","year":"2005","journal-title":"Dev Biol"},{"key":"R71-13-20210202","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/(SICI)1097-4547(19990215)55:4<504::AID-JNR10>3.0.CO;2-0","article-title":"Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus.","volume":"55","author":"Chen","year":"1999","journal-title":"J Neurosci Res"},{"key":"R72-13-20210202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.gt.3300547","article-title":"Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus.","volume":"5","author":"Chen","year":"1998","journal-title":"Gene Ther"},{"key":"R73-13-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/exnr.1997.6736","article-title":"Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors.","volume":"150","author":"Klein","year":"1998","journal-title":"Exp Neurol"},{"key":"R74-13-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.gt.3300358","article-title":"Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters.","volume":"4","author":"Peel","year":"1997","journal-title":"Gene Ther"},{"key":"R75-13-20210202","doi-asserted-by":"crossref","first-page":"12382","DOI":"10.1128\/JVI.75.24.12382-12392.2001","article-title":"Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector.","volume":"75","author":"Passini","year":"2001","journal-title":"J Virol"},{"key":"R76-13-20210202","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0896-6273(01)80026-X","article-title":"Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity.","volume":"23","author":"Arber","year":"1999","journal-title":"Neuron"},{"key":"R77-13-20210202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(02)00835-8","article-title":"Directed differentiation of embryonic stem cells into motor neurons.","volume":"110","author":"Wichterle","year":"2002","journal-title":"Cell"},{"key":"R78-13-20210202","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1523\/JNEUROSCI.21-10-03369.2001","article-title":"Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.","volume":"21","author":"Pramatarova","year":"2001","journal-title":"J Neurosci"},{"key":"R79-13-20210202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.nbd.2003.08.025","article-title":"Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery.","volume":"14","author":"Boulis","year":"2003","journal-title":"Neurobiol Dis"},{"key":"R80-13-20210202","first-page":"131","article-title":"Characterization of adenoviral gene expression in spinal cord after remote vector delivery.","volume":"45","author":"Boulis","year":"1999","journal-title":"Neurosurgery"},{"key":"R81-13-20210202","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1073\/pnas.061029798","article-title":"Herpesviruses use bidirectional fast-axonal transport to spread in sensory neurons.","volume":"98","author":"Smith","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R82-13-20210202","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1099\/0022-1317-81-9-2147","article-title":"Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study.","volume":"81","author":"Etessami","year":"2000","journal-title":"J Gen Virol"},{"key":"R83-13-20210202","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.gt.3301023","article-title":"Stable gene transfer to the nervous system using a non-primate lentiviral vector.","volume":"6","author":"Mitrophanous","year":"1999","journal-title":"Gene Ther"},{"key":"R84-13-20210202","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1006\/mcne.2001.0979","article-title":"Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment.","volume":"17","author":"Bordet","year":"2001","journal-title":"Mol Cell Neurosci"},{"key":"R85-13-20210202","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1006\/exnr.1997.6490","article-title":"Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous system neurons by retrograde axonal transport.","volume":"145","author":"Figueiredo","year":"1997","journal-title":"Exp Neurol"},{"key":"R86-13-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2004.03.007","article-title":"Tetanus toxin fragment C as a vector to enhance delivery of proteins to the CNS.","volume":"1011","author":"Francis","year":"2004","journal-title":"Brain Res"},{"key":"R87-13-20210202","doi-asserted-by":"crossref","first-page":"15434","DOI":"10.1074\/jbc.270.25.15434","article-title":"CuZn superoxide dismutase (SOD-1): tetanus toxin fragment C hybrid protein for targeted delivery of SOD-1 to neuronal cells.","volume":"270","author":"Francis","year":"1995","journal-title":"J Biol Chem"},{"key":"R88-13-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1056\/NEJMp020184","article-title":"Risks and benefits of gene therapy.","volume":"348","author":"Noguchi","year":"2003","journal-title":"N Engl J Med"},{"key":"R89-13-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/156652306776359478","article-title":"Current strategies and future directions for eluding adenoviral vector immunity.","volume":"6","author":"Bangari","year":"2006","journal-title":"Curr Gene Ther"},{"key":"R90-13-20210202","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/nbt1153","article-title":"Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors.","volume":"23","author":"Lai","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"suppl 1","key":"R91-13-20210202","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/sj.gt.3302623","article-title":"Development and application of replication-incompetent HSV-1-based vectors.","volume":"12","author":"Berto","year":"2005","journal-title":"Gene Ther"},{"key":"R92-13-20210202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1358\/dnp.2005.18.2.886481","article-title":"Current development of lentiviral-mediated gene transfer.","volume":"18","author":"Romano","year":"2005","journal-title":"Drug News Perspect"},{"key":"R93-13-20210202","first-page":"317","article-title":"Gene therapy with poxvirus vectors.","volume":"7","author":"Moroziewicz","year":"2005","journal-title":"Curr Opin Mol Ther"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002060-200705000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T13:05:44Z","timestamp":1707829544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002060-200705000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0b013e31804a83cf","relation":{},"ISSN":["0894-9115"],"issn-type":[{"value":"0894-9115","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}